News Sarepta Therapeutics, Inc. Sao Paulo

Equities

Market Closed - Sao Paulo Other stock markets 14:24:21 2024-06-25 EDT			5-day change	1st Jan Change
43.1 ^BRL	-1.87%		+33.15%	+87.72%

06-24	Morgan Stanley Adjusts Sarepta Therapeutics' Price Target to $200 From $165, Keeps Overweight Rating	MT
06-24	Evercore ISI Raises Price Target on Sarepta Therapeutics to $185 From $139, Maintains In Line Rating	MT

Morgan Stanley Adjusts Sarepta Therapeutics' Price Target to $200 From $165, Keeps Overweight Rating	06-24	MT
Evercore ISI Raises Price Target on Sarepta Therapeutics to $185 From $139, Maintains In Line Rating	06-24	MT
Key week for monetary policy	06-24
BMO Capital Raises Price Target on Sarepta Therapeutics to $200 From $170, Maintains Outperform Rating	06-24	MT
ANALYST RECOMMENDATIONS : Accenture, Walgreens Boots Alliance, Ge Vernova, Pepsico, Britvic...	06-24
Sarepta Therapeutics, Ryan Specialty rise; Autodesk, Trump Media fall, Friday, 6/21/2024	06-21	AQ
Health Care Stocks Boosted By Duchenne MS Drug -- Health Care Roundup	06-21	DJ
Sector Update: Health Care Stocks Gain in Late Afternoon	06-21	MT
S&P, Nasdaq edge down as Nvidia declines for second day	06-21	RE
Top Midday Gainers	06-21	MT
Sector Update: Health Care Stocks Edge Up in Afternoon Trading	06-21	MT
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says	06-21	MT
S&P 500, Nasdaq lower as semiconductor shares weigh	06-21	RE
Barclays Adjusts Price Target on Sarepta Therapeutics to $226 From $185, Maintains Overweight Rating	06-21	MT
Sarepta surges as investors cheer expanded use of gene therapy	06-21	RE
Tech overload on Wall Street	06-21
Wall Street set for muted open as investors await business survey data	06-21	RE
Sector Update: Health Care Stocks Steady Premarket Friday	06-21	MT
Sector Update: Health Care	06-21	MT
Nvidia Slide Stifles US Equity Futures Pre-Bell	06-21	MT

No results for this search